Gravity Stroke System for Recanalization of Large Vessel Occlusion Strokes

Starting soon · Not applicable

Conditions studied: Stroke, Ischemic Stroke, Cerebrovascular Disorders, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Vascular Disease

In brief

Supernova and Neutron are endovascular mechanical revascularization devices indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing an acute ischemic stroke within 24 hours of symptom onset or from last known well time.

Key facts

Study ID

NCT07335185

Run by

Gravity Medical Technology, INC

People needed

3000

Starts

2026-01-01

Expected to finish

2030-12-31

Last updated by the study team

2026-01-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has experienced an Acute Ischemic Stroke due to large intracranial vessel occlusion in at least one of the following intracranial vessels: internal carotid artery (ICA), M1and M2 segments of the middle cerebral artery (MCA), basilar, and vertebral artery.
• Subject has been or will be treated with Supernova and/or Neutron devices as the initial device used to remove the thrombus
• Subject is willing to participate in a 90-day follow-up visit.

You may not qualify if…

• Concurrent participation in another mechanical neurothrombectomy device trial or any other clinical trial with an active treatment arm where the study procedure or treatment might confound the results of the registry.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.